Evidence map›Paper›PMID 42177324›Full record

ArticleScientific reports2026

Participant-level anomaly detection for generation and load data using dual-side LSTMs.

Qianya He, Qi Liu, Xueliang Gong, Jiaxun Liu, Liming Yao, Tianze Yu, Tong Zhao

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qianya HeGuangdong Power Exchange Center Co., Ltd., Guangdong, China.
Qi LiuGuangdong Power Exchange Center Co., Ltd., Guangdong, China.
Xueliang GongGuangdong Power Exchange Center Co., Ltd., Guangdong, China.
Jiaxun LiuGuangdong Power Exchange Center Co., Ltd., Guangdong, China.
Liming YaoGuangdong Power Exchange Center Co., Ltd., Guangdong, China.
Tianze YuBeijing Tsintergy Technology Co., Ltd., Beijing, China.
Tong ZhaoBeijing Tsintergy Technology Co., Ltd., Beijing, China. 471560142@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reliable anomaly detection for generation and load metering data is essential to market settlement. In practice, anomalies are diverse and sparse, and the load side contains a large and time-varying number of participants, which makes fine-grained participant-level localization difficult. Conventional statistical thresholding and generic outlier detectors (e.g., LOF) are often sensitive to nonstationarity and cannot effectively exploit temporal dependency across intra-day time slots, resulting in coarse alarms and high false positives. To address these issues, this paper proposes a dual-side LSTM-based participant-level anomaly detection method. Multimodal features are constructed from 24 intra-day measurements, a daily total, FFT-derived frequency components, and calendar context. A zero-padding and masking mechanism is introduced to handle daily changes in the number of load participants without contaminating model training. A dual-layer LSTM with a 16-d participant embedding learns participant-specific temporal patterns, and a rule combining relative-error screening with confidence verification produces participant-level anomaly positioning and abnormal time-slot identification. Experiments on one-month desensitized provincial-grid data (242 generators and 78k-85k loads) achieve 100.0% F1-score (100.0% recall, 100.0% precision), with highly accurate positioning and time-slot recognition, substantially outperforming statistical and LOF baselines.

Indexed as

Anomaly detectionFrequency-domain featuresMultimodal fusionParticipant embedding

Identifiers

PMID42177324
PMCPMC13500582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.